History of Dabur India Ltd.
1975
- The Comp. was incorporated on 16th September for manufacture of high grade edible and industrial guargum powder & its sophisticated derivatives. It was incorporated in the name of Vishal Chemical [Indias] Ltd.
1981
- On 19th September, the name was changed to Vidogum & Chemicals Ltd. The capacity of plant was 2700 tpa of modified & refined guargum powder & derivatives such as oxidised guargum, carboxymethylated guargum, sydoxalkylated, guargum & similar carbo hydrate modification. It was promoted by Dabur [S. K. Burmans] Pvt. limited and founded in 1884 in Calcutta. The Comp. manufacture herbal and Ayurvedic medicines & cosmetics in India. The other products are Dabur Amla Hair Oil, Badur Chavanprash, Pudin Hara etc.
- The Comp. undertook to set up a unit at Matsya Industrial Estate, Alwar, Rajasthan for manufacture of edible & industrial grade guargum powder & its derivatives.
1992
- A new range of coconut oil under the brand name `Anmol' was launched. The Comp. developed Dab 10, an intermediate for anti-cancer drug namely Taxol.
- The Comp. undertook to implement a phytopharma project at Ghaziabad U.P. This unit would manufacture a specialised anti cancer drug Taxot apart from manufacture of chemical intermediary for cancer drug and Terfenadine a non sedative anti allergic drug. The installed capacity of Taxot, the intermediate drug & anti allergic drug would be `6 Kg, 40 Kgs. & 18 tonnes respectively.
- The Comp. entered into a joint venture agreement with M/s. Guldenhorst BV Netherland to form a Comp. for manufacture and marketing of all types of bubble gum, chewing gum, toffees, chocolate and cocoa related products, sugar based spreading creams etc. The company co-promoted Dabur Finance limited to carry on the business of leasing, financing etc. - 45,50,520 shares allotted. Pursuant to a scheme of amalgamation of Dabur with Vidogum.
1994
- New products launched were `Dentacare,' Vatika & Lactonic which were well received in the market.
- An integrated facility was designed at Alwar for manufacture of Ayurvedic Veterinary range at Alwar, a joint venture in technical collaboration with Shikobo Ltd., Japan to extend the range of natural gum products into speciality products.
- The Comp. also undertook to set up a project in Himachal Pradesh for manufacture of Hajmola, honey, Gulabari, Pudin Hara, Lavan Bhaskar Churna & soft gel capsules, part of existing range of products.
- At its Sahibabad plant, the Comp. undertook to install various balancing equipments, mechanise operations, hitherto performed manually, instal reverse Osmosis plant, a concentration plant for extraction of herbs, barks, roots, seed etc.
- The Comp. also undertook to upgrade amla pulping section, expand storage space for ayurvedic raw materials & to meet the cost of the installation of two additional DG sets.
- The Comp. floated two companies a manufacturing unit in Egypt in the name of Dabur Egypt limited & Dadur International limited in BVI. The company entered into a joint venture with Seprache International Ltd. in the name of `Innova' Inc. For manufacture of anti cancer drug namely `Paclitaxel'.
- The Comp. signed a MOU with Osein Internatinal limited for manufacture of biscuits, snack, foods and other products in India.
1995
- In addition to the existing products, the Comp. exported products like an improved version of Chyawanprash [with more honey & less pungencys] liquid form of Chyawanprash an aqueous based, hair vitalizer Melatonine etc.
- 182,02,080 bonus equity shares issued in prop. 4:1. During November 1993, the Comp. issued 57,00,000 equity shares of Rs 10 lakh at a prem. of Rs 85 per share of which the following were reserved for allotment on a preferential basis: [1s] 2,64,000 shares to employees of the company shareholders of group cos. [all were taken ups]; [2s] 5,27,000 shares to NRIs [all were takens]; [3s] 11,40,000 shares to Indian Fin. Insts. [only 8,38,400s] shares taken up; [4s] 5,40,000 shares to FIIs [all were taken ups]; [5s] 6,00,000 shares to Indian Mutual Funds [all were taken ups]. Balance 26,29,000 shares along with 3,01,600 shares not taken up by FIIs, issued to public. Additional 56,530 equity shares allotted. 1996
- The Comp. launched Madhuvanni an anticough preparation.
- A unit was being set up at Baddi for manufacture of Chywanprash Janma Ghunti, Lal Tail, Dashmularishta & Ashokarishta. Semi synthetic pacitaxel & Docetaxel & various front line anti cancer drugs were being produced both for domestic as well as export market. The company proposed to double the volume of Katni plant & introduce modern technology in processing Amla with high productivity & improved quality.
- The Comp. undertook to set up a joint venture in Bangrain of France in the names of Dabon International Pvt. limited Another joint venture viz. General de Confiteria Pvt. limited commenced commerical production in April 1995. 1997
- The Comp. set up a new manufacturing unit with a high degree of automation at Baddi [H.P.s], to produce company well known brands viz. Chyawanprash, Janma Ghunti, Ayurvedic oils & Asva-Arishtas. A modern air conditioned packing line was commissioned at Sahibabad for homemade brands of ethnic pastes & line juices.
- The Dabur India Ltd has formed a joint venture with Osem of Israel for the production of food product in India. The joint venture named as Excelcia Food Pvt Ltd will have the Rs.15 paid up capital in which Dabur will have 60 per cent stake while Osem will have the rest 40 per cent holding in the company.
- The Comp. extended its range of real fruit juice by offering mixed fruit juice & tomato juice. Its veterinary division launched `mastilep' for curing mastitis in cattle.
- Dabur India launched a range of extruded snack foods, ready-to-use cooking pastes & sauces here on Thursday.
- Dabur India is negotiating with Antonio Puig of Spain, the maker of the Paco Rabanne perfume range, & Kesling of France to set up joint ventures in the country as a part of its strategy to establish a strong presence in the personal care sector.
- Dabur India Ltd, Great Eastern Shipping Comp. Ltd & Ranbaxy Laboratories limited have signed agreements with NSDL to get their securities admitted for dematerialisation at NSDL.
- Dabur Industries Ltd has signed a tripartite agreement with the National Securities Depository Ltd & MCS ltd for dematerialising Dabur shares, becoming the first MCG Comp. to avail of facility.
- Dabur India Ltd is launching a new communication campaign this month to reposition its oldest brand - `Pudinhara'.
1998
- Dabur India Ltd on 19th January 1998 launched low sodium cooking salt called Nutrasalt in Chandigrah.
- Dabur signed a joint venture with Bongrain International SA of France to form a new Comp. called Dabon International Ltd
- Dabur India Ltd has launched a range of ayurvedic health care products for dogs under the umbrella brand name Ayupet.
- Dabur India Ltd [DILs] has commissioned consultancy firm Noble and Hewitt to script a employee stock option plan.
- Dabur India has tied up with Godrej Foods for manufacture and packaging of its `Real' range of fruit juices & fruit drinks in tetrapacks.
1999
- Dabur India Ltd has entered into an agreement with its Spanish partner Agrolimen to offload its 49 per cent stake in the joint venture company General De Confiteria India Ltd in favour of an Agrolimen group company.
- Dabur Pharmaceuticals Limited [DPLs] has set up its first overseas arm in Britain with a $5 million investment commitment & is considering similar ventures in Russia as well as South African countries.
2000
- The Comp. has taken Nestle SA to the Comp. Law Board [CLBs] charging the latter with 'arm-twisting' it as a majority shareholder in their biscuit manufacturing joint venture Excelcia Foods Ltd [EFLs].
- FMCG major Dabur, along with US insurance Comp. Allstate and Prudential-ICICI joint venture have applied for life insurance license as the Insurance Regulatory & Development Authority .
- The Comp. has divested its entire 40 per cent stake in the controversial joint venture Excelcia Foods with Swiss major Nestle SA for a token amount of Rs 10.
- The Comp. sub-divide the fully paid-up equity shares of Rs. 10 each into 10 fully paid-up equity shares of Re. 1 each.
- Three domestic pharma companies - Cadila Pharmaceuticals, Shantha Biotech & Dabur India have signed an agreement with the department of biotechnology [DBTs] for developing & marketing basic molecules in leprosy, hepatitis & tumor disease segments.
- Crisil reaffirmed the highest safety rating of `P1+' to the company's Rs 100-crore commercial paper programme. Crisil has reaffirmed it AA rating, indicating high safety, assigned to the Rs 20 crore non-convertible debenture issue of company.
- Dabur India Ltd., has launched Efarelle Comfort, a natural menstrual pain reliever.
- Dabur India ayurvedic specialities division has launched plain isabgol husk under the brand name Nature Care.
2001
- Dabur India limited proposes to increase the number of directors on its board, by adding three new directors. 2002
- Dabur India Ltd has informed that Mr. Ninu Khanna would now be continuing as CEO and Director till the Date of next Board Meeting scheduled to be held on January 22, 2002.
2002
- Dabur India Ltd has informed that Mr.Ninu Khanna has resigned as Chief Executive Officer & Director of Comp. & the resignation has been accepted.
- Dabur India Ltd has informed that the Compensation Committee has allotted 16660 fully paid equity shares of Re 1 each for cash at par to the employees of Company.
- Dabur India Ltd has informed that the Board of Directors has approved the restructuring of Board. Mr A CBurman, Mr Sidharth Burman, Air Chief Marshal N C Suri [Retds], Mr S M Datta, Mr Raja Vijay Karan.Mr Ashok Goenka have resigned from the Directorship of Comp. & the Board has accepted the same w e f April 1, 2002.Further, Mr V C Burman and Mr Pradip Burman have also resigned from the Whole-time Directorship of Company. Mr V C Burman & Mr Pradip Burman will, however continue as Non-executive Directors of Company.
-Pradip Burman appointed as Whole time Director of Dabur India.
-The Board of Directors of Dabur India Ltd has appointed Mr Sunil Duggal as Chief Executive Officer of Comp. wef July 01, 2002.
2003
-The fourth Largest FMCG, Dabur India Ltd has tied with Free Markets Inc. for using leading edge technologies to execute online markets for its procurement needs.
-CRISIL assigned 'CRISIL GVC LEVEL 2' rating for governance & value creation practices of company.
-Dabur has sued Pharmaseutical major Ranbaxy for telecasting the comparative commercial of 'Pepfiz'.
-Dabur India has inducted Mr.Siddharth Burman as the chairman & Mr Sunil Duggal, Mr.P D Narang & Mr Charanjit Mohan as the directors of 4-member board of Dabur India global arm based in Dubai.
-The Comp. acquired 10,00,000 ordinary fully paid shares of 1 Pound Sterling each of Redrock Limited with this acquisition Redrock Limited has become a wholly owned subsidiary of company. Redrock Limited is engaged in the business of manufacture & sale of various cosmetics, toiletries & health care products & operates from the Jebel Ali Free Trade Zone in Dubai.
-Acquires equity in Shri Dhanwantry Educational Society
-Dabur forges alliance with Dhanwantry
-Dabur launch new Herbal pill for diabetics
2004
-Dabur set to acquire Egyptian hair oil brand Touch
-Dabur India gets Tetra Pak award
-Dabur India inks pact with Accenture for outsourcing
-Implements `Spend visibility solution' software provided by FreeMarkets Inc to control costs & strengthen the company procurement process
-Dabur ties up Uttarnachal for cancer drug
-Dabur India has acquired a Nigerian Comp. African Consumer Care Ltd, a step precursor to its plans to go on-shore for manufacturing in the country
-Dabur join hands with DLF for healthcare hub
2005
-Delists equity shares from The Calcutta Stock Exchange Association Ltd [CSEs] with effect from January 27, 2005,
- Completes the acquisition process of Balsara Hygiene Products Ltd and Besta Cosmetics Ltd on April 16, 2005.
2006
-Dabur Director P D Narang appoints as Chairman of PTL
2007
-The Comp. has issued Bonus Shares in the Ratio of 1:2.
